Parsippany, NJ, United States of America

Jing Zhang

This inventor holds 15 USPTO granted patents and 4 published patent applications and 9 EPO patents, primarily in Antiviral Compounds. Top assignees: Hoffmann-La Roche Inc., Allelix Neuroscience Inc., Riboscience LLC. Active years: 1999-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Zhang. Retrieved from https://idiyas.com/inventor/jing-zhang-0i0vtqml

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 26.7

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 141(Granted Patents)


Location History:

  • East Brunswick, NJ (US) (1999 - 2006)
  • Parsippany, NJ (US) (2001 - 2017)

Company Filing History:


Years Active: 1999-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleoside Derivatives
HCV RNA Replication
Bruton's Tyrosine Kinase
Antiviral Compounds
Spiroindolinones
Oxindole Derivatives
Pharmaceuticals
Neurological Disorders
Neuropsychiatric Disorders
Pyrrolidine Carboxamides
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Jing Zhang

Introduction

Jing Zhang, an accomplished inventor based in Parsippany, NJ, has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With an impressive portfolio of 15 patents, Zhang's work focuses on innovative solutions for combating viral infections, specifically Hepatitis C Virus (HCV).

Latest Patents

Among Zhang's latest patents are groundbreaking inventions such as the "4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication." This invention outlines the use of specific nucleoside phosphoramidate prodrug derivatives aimed at creating effective pharmaceutical compositions for treating HCV. Another notable patent he holds is for "Antiviral compounds," which discloses compounds designed to prevent or treat HCV infections, further highlighting Zhang's commitment to advancing antiviral therapies.

Career Highlights

Throughout his career, Jing Zhang has had the opportunity to work with renowned companies such as Hoffmann-La Roche Inc. and Allelix Neuroscience Inc. His roles in these organizations have allowed him to spearhead research initiatives and innovate pharmaceutical solutions that address critical healthcare challenges.

Collaborations

Collaboration has played a crucial role in Zhang’s achievements. He has worked alongside talented colleagues, including Zhuming Zhang and Qingjie Ding, who have contributed to his research endeavors. These partnerships exemplify the collaborative spirit that drives innovation in the pharmaceutical industry.

Conclusion

Jing Zhang's dedication to innovation and his significant contributions to antiviral research make him a prominent figure in the field. With a solid track record of patents and collaborations, Zhang continues to pave the way for new therapies in the fight against viral infections, reflecting the importance of creativity and persistence in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…